(AMST) Amesite Operating - Ratings and Ratios

Amesite Operating Co (NASDAQ:AMST) is a technology firm that leverages AI-driven solutions to cater to both consumer and business needs in the US market. The companys product suite includes Amesite Engage, a platform that enables educational institutions to offer skill-building courses, and NurseMagic, a healthcare app designed to support nurses and caregivers in managing their tasks and stress. By serving enterprises, universities, and K-12 schools, Amesite has positioned itself at the intersection of education and technology.

With its foundation in 2017, Amesite has established its headquarters in Detroit, Michigan, and has been working towards creating innovative solutions. The companys focus on AI-driven products indicates a commitment to staying ahead in the technological curve. NurseMagic, in particular, addresses a critical need in the healthcare sector by providing support to professionals, thereby improving their productivity and job satisfaction.

Analyzing the technical data, AMSTs stock has shown a level of volatility, as indicated by its ATR of 0.26, which translates to an 8.62% fluctuation. The stock price is currently at $3.05, above both its 20-day and 50-day Simple Moving Averages (SMA20 and SMA50) of $2.47 and $2.36, respectively. However, it remains below its 200-day SMA of $2.77 is not the case, it is actually above, indicating a potential short-term bullish trend but a longer-term bearish trend. Given its 52-week high and low of $5.11 and $2.01, respectively, the stock has shown significant price movement.

From a fundamental perspective, Amesites market capitalization stands at $13.18M USD, with no P/E ratio due to likely negative earnings. The Return on Equity (RoE) is significantly negative at -158.86%, indicating substantial losses relative to shareholder equity. This suggests that the company is still in a growth phase, investing heavily in its products and market expansion.

Forecasting the stocks performance based on the available technical and fundamental data, a potential short-term upward trend could be anticipated if the stock continues to trade above its SMA20 and SMA50. However, the lack of profitability and significant negative RoE raise concerns about the companys long-term viability. If Amesite can successfully scale its products and achieve profitability, the stock could see an upward revaluation. Conversely, failure to address its financial performance could lead to a decline in stock price. A key level to watch would be the stocks ability to sustain its price above $3.05 and potentially move towards its 52-week high of $5.11. Conversely, a drop below $2.47 could signal a further decline.